Food industry embraces 'GLP-1 friendly' label

The “GLP-1 friendly” label is moving from niche wellness language into mainstream food marketing as more Americans take drugs such as Wegovy, Zepbound and Ozempic. The Food Institute reported on May 20 that food makers are pitching smaller, protein- and fiber-heavy meals to shoppers whose appetites have been reduced by GLP-1 medicines. Associated Press reported in January that those labels were already appearing on supermarket shelves, including at Kroger stores, even though the claim is not regulated by the U.S. Food and Drug Administration. The shift reflects a simple commercial problem for food companies. J.P. Morgan data cited by The Food Institute said GLP-1 users consume about 21% fewer calories and spend 31% less on groceries than before starting the drugs, with a projected annual industry revenue hit of $30 billion to $55 billion by 2030 to 2034. KFF said in a November 2025 poll that 12% of U.S. adults were currently taking a GLP-1 drug for weight loss, diabetes or another condition. (foodinstitute.com) ### What are companies actually putting under the “GLP-1 friendly” label? NielsenIQ executive Sherry Frey told The Food Institute that her firm has started tracking products with “GLP-1 friendly” claims and found sales up 11.2% over the last 52 weeks. Frey said NielsenIQ’s working definition centers on products high in protein, fiber and unsaturated fat and low in added sugar and saturated fat, while noting there is no formal standard for the term. (foodinstitute.com) Novant Health dietitian Kelly Homesley said on April 30 that the label generally points shoppers toward smaller-portion foods with more protein and fiber than comparable products. Homesley said brands including Nestle and Conagra were selling products with labels such as “GLP-1 Friendly” or “On Track,” and that some retailers were grouping such items together in dedicated store sections. (foodinstitute.com) ### Why are retailers and manufacturers leaning into this now? The Food Institute said shoppers taking GLP-1 drugs are not only eating less but also cooking less, pushing demand toward convenience foods in smaller portions. The report cited Utah resident Al Salomon, who told Bloomberg that the medication reduced both hunger and interest in preparing meals, leading her to keep frozen meals on hand instead of cooking from scratch. (novanthealth.org) Kroger said on February 24 that it was pairing GLP-1 prescription savings programs with nutrition support, dietitian access and in-store food options rich in protein and fiber. Colleen Lindholz, president of Kroger Health, said the company was trying to provide medication access, pharmacy guidance and practical nutrition support in one place. (foodinstitute.com) ### Does “GLP-1 friendly” mean the food is medically vetted? The FDA does not regulate “GLP-1 friendly” food labels, according to the Associated Press report published in January. That leaves the term closer to a marketing claim than a medical designation, and dietitians interviewed by AP said shoppers still need to read ingredient labels and assess their own nutrition needs. (ir.kroger.com) UCHealth dietitian Shannon Christen told AP that people on GLP-1 drugs may eat around 50% less than before, which makes nutrient density more important. Christen said she generally recommends 20 to 30 grams of protein per meal, while Ohio State dietitian Samantha Snashall said fiber matters in part because constipation is a common side effect of the drugs. (ap.org) ### Are dietitians convinced these products deliver what the label suggests? Novant Health’s Homesley said the label can help busy shoppers find higher-protein, higher-fiber prepared meals, but she said she would not recommend those products as the default everyday diet. Homesley said some meals marketed to GLP-1 users still fall short of the protein and fiber levels she recommends for patients. (ap.org) The Food Institute also cited Frey as saying some GLP-1 users may fall short on vitamins and minerals including calcium, iron, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C. That has helped push companies toward nutrient-dense positioning rather than simple calorie reduction. ### What comes next as GLP-1 use spreads? (novanthealth.org) The Baltimore Sun reported on May 20 that weight lost on GLP-1 drugs can return after treatment stops, and that researchers are studying oral GLP-1 medicines and gut-bacteria supplements as possible ways to support longer-term weight management. Separately, NEJM Clinician reported in April that the FDA had approved oral GLP-1 drug orforglipron for obesity and overweight, adding a pill option to a market dominated by injections. (foodinstitute.com) KFF said about one in five adults had ever taken a GLP-1 medication as of March 2026, including 12% currently taking one. As that user base grows, the next evidence to watch will come from clinical guidance, retailer merchandising and whether regulators or industry groups move to define what “GLP-1 friendly” can mean on a package. (kff.org) (clinician.nejm.org)